FDA Lifts Ban Affecting Salmon Facility in Indiana

WASHINGTON – Today, U.S. Senator Todd Young (R-Ind.) applauded the U.S. Food and Drug Administration (FDA)’s announcement that it will deactivate an import alert on genetically engineered (GE) salmon and salmon eggs from entering the U.S. This is welcome news in Albany, Indiana, where AquaBounty made a $14 million investment – purchasing a defunct fish facility for cultivating GE salmon. The FDA had previously approved the facility and the product for human consumption, but production could not begin due to a provision in the 2016 Omnibus Appropriations Act that resulted in FDA issuing an import ban. 

This important investment could create up to 100 jobs and help revive the local economy. Cultivating other sources of seafood will also provide consumers with healthier options, which helps improve the health of Indiana’s population. 

“This announcement is good news for Albany and Delaware County, where this emerging industry has the potential to create jobs and spark economic activity,” said Senator Young. “I have been vocal with the FDA and my Senate colleagues about this issue, and am pleased that the FDA has acted.”